Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Ipsen S.A.
(OP:
IPSEF
)
113.13
UNCHANGED
Last Price
Updated: 3:47 PM EDT, Jun 9, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
113.13
Bid (Size)
N/A (0)
Ask (Size)
N/A (0)
Prev. Close
113.13
Today's Range
113.13 - 113.13
52wk Range
103.50 - 124.41
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Third Time Lucky: Exelixis' Cabozantinib Combo Therapy Aces Pivotal Study In Prostate Cancer Patients
↗
August 21, 2023
Roche Holdings AG (OTC: RHHBY), Exelixis Inc (NASDAQ: EXEL), and Ipsen&nbs
Via
Benzinga
What Now After FDA AdComm Rebuke for Intercept Pharmaceutical? Analyst Says Approval Of Intercept's 'OCA In NASH May Never Occur
↗
May 22, 2023
On Friday, FDA's Gastrointestinal Drugs Advisory Committee voted 12 to 2—with two abstentions—that the benefits of Intercept Pharmaceutical Inc's ICPT Ocaliva 25 mg, also known as Obeticholic acid...
Via
Benzinga
Performance
YTD
N/A
N/A
1 Month
N/A
N/A
3 Month
N/A
N/A
6 Month
N/A
N/A
1 Year
-9.1%
-9.1%
More News
Read More
France-Based Ipsen Acquires Albireo Pharma Enriching Its Rare Disease Portfolio, Pipeline
↗
January 09, 2023
Via
Benzinga
Why Merrimack Shares Are Surging Over 200% Today?
↗
November 09, 2022
Via
Benzinga
Merrimack Pharma-Ipsen's Cancer Drug Fails In Overall Survival Measure
↗
August 03, 2022
Via
Benzinga
Why Is Epizyme (EPZM) Stock Up 75% Today?
↗
June 27, 2022
Via
InvestorPlace
Ipsen Scoops Up Blood Cancer-Focused Epizyme - Read Why
↗
June 27, 2022
Via
Benzinga
Ipsen - Exelixis' Cabometyx Scores European Approval As Second-Line Treatment For Thyroid Cancer
↗
May 03, 2022
Via
Benzinga
EMA's Scientific Committee Backs Expanded Use Of Exelixis, Ipsen's Cabometyx In Thyroid Cancer
↗
March 25, 2022
Via
Benzinga
Ipsen's Sohonos Scores Canadian Approval For Rare Connective Tissue Disease
↗
January 24, 2022
Via
Benzinga
Genfit Shares Rally After Ipsen Buys Rights To Its Late-Stage Kidney Disease Treatment Hopeful
↗
December 17, 2021
Via
Benzinga
Ipsen Stock Declines After Pulling Rare Disease Application
↗
August 13, 2021
Via
Benzinga
Exicure Stock Surges On Over $1B Option Licensing Pact With Ipsen For Rare Neurodegenerative Disorders
↗
August 02, 2021
Via
Benzinga
Ipsen Beefs Up Pre-Clinical Oncology Pipeline With Over $850M Deal With BAKX Therapeutics
↗
July 27, 2021
Via
Benzinga
Exelixis Shares Drop On Mixed Results For Cabometyx Combo In Early Liver Cancer
↗
June 28, 2021
Via
Benzinga
Frequently Asked Questions
Is Ipsen S.A. publicly traded?
Yes, Ipsen S.A. is publicly traded.
What exchange does Ipsen S.A. trade on?
Ipsen S.A. trades on the OTC Traded
What is the ticker symbol for Ipsen S.A.?
The ticker symbol for Ipsen S.A. is IPSEF on the OTC Traded
What is the current price of Ipsen S.A.?
The current price of Ipsen S.A. is 113.13
When was Ipsen S.A. last traded?
The last trade of Ipsen S.A. was at 06/09/25 03:47 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.